Asmacure has commenced phase 1/2 trial of ASM-024 dry powder for inhalation (DPI) formulation with multi-functional mechanism of action with nicotinic and muscarinic effects. In pre-clinical asthma models ASM-024 exhibited the ...
Tags: Asmacure, Dry Powder, Inhalation